Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.

First American Financial Corp (FAF)

8-K Earnings release confidence 98% filed 2026-10-21 Item 2.02

First American Financial Corporation issued a press release on October 21, 2026, announcing its financial results for the quarter ended September 30, 2026. The disclosure includes quarterly earnings per diluted share of $1.72 ($1.78 adjusted), total revenue of $2.1 billion (up 5% year-over-year), net income of $177 million, and segment-level performance metrics. This is a standard quarterly earnings release furnished under Item 2.02 and attached as Exhibit 99.1.

View raw filing on EDGAR →

Invesco Galaxy Bitcoin ETF (BTCO)

8-K Exec appointment confidence 85% filed 2026-10-21 Item 5.02

Ms. Lori Anello was appointed as Principal Financial and Accounting Officer of Invesco Capital Management LLC (the Sponsor) effective October 22, 2026, following Ms. Kelli Gallegos's leave of absence. The appointment of a Principal Financial and Accounting Officer—a key financial leadership role—is material to investors' assessment of the fund's governance and financial oversight. While the filing also discloses a departure (Gallegos's leave), the principal disclosed action centers on Anello's appointment to this critical officer position.

View raw filing on EDGAR →

QuantumScape Corp (QS)

8-K Earnings release confidence 95% filed 2026-10-21 Item 2.02

QuantumScape announced its Q3 2026 business and financial results on October 21, 2026, with a shareholder letter and press release furnished as Exhibits 99.1 and 99.2. The disclosure includes condensed consolidated financial statements (balance sheet, income statement, cash flows), operating metrics (customer billings of $9.8M, capex of $4.4M), and full-year 2026 guidance (Adjusted EBITDA loss of $250M–$275M, capex of $27M–$37M). This is a standard quarterly earnings release material to investors assessing the registrant's financial condition and operational progress.

View raw filing on EDGAR →

WESBANCO INC (WSBCO)

8-K Earnings release confidence 99% filed 2026-10-21 Item 2.02

WesBanco issued a press release announcing earnings for the three and nine months ended September 30, 2026, disclosing net income of $85.3 million (Q3 2026) and $258.1 million (nine months 2026) with corresponding diluted EPS of $0.88 and $2.67 respectively. The press release, attached as Exhibit 99.1, contains comprehensive financial results including balance sheet metrics, credit quality, net interest margin, and capital ratios—all hallmarks of a quarterly earnings disclosure under Item 2.02.

View raw filing on EDGAR →

HEXCEL CORP /DE/ (HXL)

8-K Earnings release confidence 98% filed 2026-10-21 Item 2.02

Hexcel Corporation issued a press release on October 21, 2026 announcing third quarter 2026 financial results, including net sales of $496.4 million (8.8% increase year-over-year), GAAP diluted EPS of $0.50, and adjusted diluted EPS of $0.50, with full-year 2026 guidance reaffirmed.

View raw filing on EDGAR →

Alaunos Therapeutics, Inc. (TCRT)

8-K Delisting risk confidence 95% filed 2026-10-21 Item 3.01

The filing discloses Alaunos' receipt of a Nasdaq deficiency notice on April 9, 2026 for failure to maintain the $2.5 million stockholders' equity requirement, followed by a delisting notice on October 5, 2026 due to continued non-compliance. Although the Company claims to have regained compliance through the October 14, 2026 financing ($350 million in proceeds), the disclosure explicitly states that Nasdaq will continue monitoring compliance and "if at the time of the filing of the Company's Annual Report on Form 10-K for the fiscal year ending December 31, 2026 the Company does not evidence compliance, the Company may be subject to delisting." This is a classic delisting-risk disclosure under Item 3.01, with material uncertainty about sustained compliance.

View raw filing on EDGAR →

Lake Shore Bancorp, Inc. /MD/ (LSBK)

8-K Earnings release confidence 98% filed 2026-10-21 Item 2.02

Lake Shore Bancorp issued a press release on October 21, 2026 disclosing third-quarter 2026 financial results, including net income of $2.3 million ($0.31 per diluted share) and year-to-date results of $6.4 million ($0.87 per diluted share). The filing presents comprehensive quarterly and nine-month financial highlights, net interest income analysis, non-interest income and expense details, and credit quality metrics—all hallmarks of a standard earnings release under Item 2.02.

View raw filing on EDGAR →

Third Coast Bancshares, Inc. (TCBX)

8-K Earnings release confidence 97% filed 2026-10-21 Item 2.02

Third Coast Bancshares issued a press release on October 21, 2026 announcing its financial results for the quarter ended September 30, 2026, including net income of $19.0 million, earnings per share of $1.07 basic and $0.93 diluted, net interest margin of 3.70%, and return on average assets of 1.13%. The company also announced an investor call and webcast to discuss the quarterly results.

View raw filing on EDGAR →

Evercore Inc. (EVR)

8-K Exec appointment confidence 92% filed 2026-10-21 Item 5.02

The filing discloses the appointment of Nigel Dawn and Naveen Nataraj as Co-Presidents of Evercore, effective January 1, 2027, representing a material promotion of two senior executives to newly created leadership roles reporting directly to the CEO. While the disclosure also includes compensatory arrangements (PRSUs worth $20 million each), the principal disclosed action centers on the appointment itself, which materially affects the firm's senior leadership structure and succession planning.

View raw filing on EDGAR →

FMC CORP (FMC)

8-K Debt Issuance confidence 80% filed 2026-10-21 Item 2.03

FMC entered into Amendment No. 8 to its Fifth Amended and Restated Credit Agreement on October 15, 2026, which materially modifies the terms and covenants of the existing credit facility. The amendment adds a covenant requiring use of proceeds from the India sale for debt repayment and conditionally releases guarantors and collateral, constituting a material modification to the Company's direct financial obligations.

View raw filing on EDGAR →

ARMSTRONG WORLD INDUSTRIES INC (AWI)

8-K Dividend Distribution confidence 98% filed 2026-10-21 Item 8.01

Armstrong's Board declared a quarterly cash dividend of $0.373 per share, representing a 10% increase from the prior dividend and marking the eighth consecutive annual increase since 2018. This is a clear dividend distribution event. The materiality is high given the company's explicit capital allocation strategy and the signal it sends about financial health and shareholder returns.

View raw filing on EDGAR →

Dell Technologies Inc. (DELL)

8-K Exec appointment confidence 85% filed 2026-10-21 Item 5.02

The filing discloses the appointment of Christopher Garcia as Executive Vice President, General Counsel and Secretary (chief legal officer) effective February 1, 2027, following Richard Rothberg's announced retirement. While both a departure and appointment occur, the principal disclosed action centers on Garcia's appointment to a C-suite legal role, making exec_appointment the most salient classification. This is material as it involves succession planning for a senior executive position responsible for legal and governance functions.

View raw filing on EDGAR →

CrossAmerica Partners LP (CAPL)

8-K Dividend Distribution confidence 95% filed 2026-10-21 Item 7.01

The filing announces approval of a quarterly distribution of $0.5250 per unit for Q3 2026, payable November 12, 2026. This is a routine but material distribution declaration by a master limited partnership (MLP) to unitholders, consistent with the prior quarter and annualized at $2.10 per unit. The disclosure directly addresses the declaration and payment terms of a distribution to security holders.

View raw filing on EDGAR →

KAISER ALUMINUM CORP (KALU)

8-K Earnings release confidence 98% filed 2026-10-21 Item 2.02

Kaiser Aluminum issued a press release on October 21, 2026 reporting preliminary, unaudited financial results for Q3 2026, including net sales of $1.2 billion, net income of $31 million ($1.84 per diluted share), and adjusted EBITDA of $84 million. The disclosure is filed under Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings releases. The filing includes detailed financial tables, management commentary, and forward guidance, all hallmarks of an earnings release.

View raw filing on EDGAR →

Alpha Teknova, Inc. (TKNO)

8-K Dilutive issuance confidence 92% filed 2026-10-21 Item 1.01

Alpha Teknova entered into an underwriting agreement on October 20, 2026 for a registered public offering of 8,000,000 shares at $5.00 per share, generating $40 million in gross proceeds, with an additional 1,200,000-share option granted to underwriters. This material registered equity issuance dilutes existing shareholders and raises capital for general corporate purposes including potential debt repayment.

View raw filing on EDGAR →

Alpha Teknova, Inc. (TKNO)

8-K Earnings release confidence 75% filed 2026-10-21 Item 2.02

Alpha Teknova disclosed preliminary Q3 2026 financial results including revenue of $12.5–$12.7 million, gross margin of 36–38%, and negative Adjusted EBITDA of $1.2–$1.0 million, subject to completion of financial closing procedures.

View raw filing on EDGAR →

GETTY REALTY CORP /MD/ (GTY)

8-K Earnings release confidence 98% filed 2026-10-21 Item 2.02

Getty Realty Corp. issued a press release on October 21, 2026, announcing its financial and operating results for the quarter ended September 30, 2026. The disclosure includes quarterly net earnings ($0.40 per share), FFO ($0.61 per share), AFFO ($0.64 per share), and updated 2026 full-year AFFO guidance (increased to $2.53–$2.54 per share). This is a standard quarterly earnings release for a publicly traded REIT, disclosed under Item 2.02 and furnished as Exhibit 99.1.

View raw filing on EDGAR →

CIVISTA BANCSHARES, INC. (CIVB)

8-K Dividend Distribution confidence 98% filed 2026-10-21 Item 8.01

The Board of Directors has approved and declared a quarterly dividend of 18 cents per common share, payable to shareholders of record as of November 3, 2026, on November 17, 2026. This represents a $3.7 million payout and is consistent with prior quarters. The disclosure is a straightforward dividend declaration, which is a material capital distribution event that investors monitor as an indicator of financial health and capital allocation policy.

View raw filing on EDGAR →

Stepstone Private Credit Fund LLC

8-K Dilutive issuance confidence 95% filed 2026-10-21 Item 3.02

Stepstone Private Credit Fund LLC completed an unregistered sale of 2,123,951 LLC interests for $54.8 million pursuant to subscription agreements, conducted under Section 4(a)(2), Regulation D, and Regulation S exemptions. This private placement represents a significant capital raise and is materially dilutive to existing investors.

View raw filing on EDGAR →

Stepstone Private Credit Fund LLC

8-K Dividend Distribution confidence 85% filed 2026-10-21 Item 8.01

The fund declared and announced a Q3 2026 distribution of $0.57 per share payable on October 30, 2026, to shareholders of record as of September 29, 2026. This represents a recurring but material capital allocation event for the closed-end fund.

View raw filing on EDGAR →

Red Rock Resorts, Inc. (RRR)

8-K Debt Issuance confidence 95% filed 2026-10-21 Item 2.03

Station Casinos LLC, a subsidiary of Red Rock Resorts, entered into an incremental joinder agreement on October 21, 2026, creating $500 million in new incremental term B loans under its senior secured credit agreement. The proceeds are intended for revolving loan repayment and general corporate purposes.

View raw filing on EDGAR →

MSD Investment Corp.

8-K Dilutive issuance confidence 95% filed 2026-10-21 Item 3.02

MSD Investment Corp. issued 6,334,459 shares of common stock for approximately $150 million to existing stockholders pursuant to subscription agreements and capital drawdown notices. The issuance was made under Section 4(a)(2) of the Securities Act and Regulation D, relying on accredited investor representations. This is a classic unregistered equity issuance under Item 3.02, representing a material capital raise that dilutes existing shareholders and affects the company's capitalization structure.

View raw filing on EDGAR →

BANCFIRST CORP /OK/ (BANFP)

8-K Earnings release confidence 98% filed 2026-10-21 Item 2.02

BancFirst Corporation disclosed its third quarter 2026 financial results on October 21, 2026, reporting net income of $67.3 million ($1.97 per diluted share) compared to $62.7 million ($1.85 per diluted share) in Q3 2025. The disclosure includes a comprehensive press release with detailed income statements, balance sheet data, asset quality metrics, and performance ratios for the quarter and nine-month period. This is a standard quarterly earnings release filed under Item 2.02, which is material to investors assessing the company's financial performance and condition.

View raw filing on EDGAR →

Fortress Private Lending Fund

8-K Dilutive issuance confidence 95% filed 2026-10-21 Item 3.02

Fortress Private Lending Fund sold 592,007 Class I common shares for $14.3 million in aggregate consideration to accredited investors pursuant to Section 4(a)(2) and Regulation D exemptions.

View raw filing on EDGAR →

Fortress Private Lending Fund

8-K Dividend Distribution confidence 92% filed 2026-10-21 Item 8.01

The fund declared the October 2026 Distribution of $0.1834 per share, payable to shareholders of record as of October 31, 2026, with payment on or about November 23, 2026.

View raw filing on EDGAR →

MATTEL INC /DE/ (MAT)

8-K Exec appointment confidence 95% filed 2026-10-21 Item 5.02

Mattel appointed Lee Matheson, a Partner at EdgePoint Investment Group (an ~18% shareholder), to its Board of Directors effective October 21, 2026, increasing board size from nine to ten members. The appointment was made pursuant to a cooperation agreement with EdgePoint that includes voting commitments, standstill restrictions, and director replacement rights.

View raw filing on EDGAR →

Leslie's, Inc. (LESL)

8-K Bankruptcy Filing confidence 99% filed 2026-10-21 Item 1.03

Leslie's, Inc. and nine subsidiaries filed voluntary petitions under Chapter 11 of the Bankruptcy Code on September 30, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas. The filing is pre-arranged with a restructuring support agreement and includes a joint plan of reorganization filed on October 20, 2026. This is a terminal event materially threatening the registrant's continued existence and is the core disclosure of Item 1.03.

View raw filing on EDGAR →

PACKAGING CORP OF AMERICA (PKG)

8-K Earnings release confidence 98% filed 2026-10-21 Item 2.02

This is a straightforward earnings release for Q3 2026. The Item 2.02 disclosure states that "On October 21, 2026, Packaging Corporation of America issued a press release announcing third quarter financial results," with the press release furnished as Exhibit 99.1. The exhibit contains detailed financial results including net income of $262 million ($2.93 per share), net sales of $2.6 billion, segment operating income, and forward guidance for Q4 2026 earnings of $2.81 per share excluding special items. This is a material disclosure affecting investor assessment of the registrant's financial performance.

View raw filing on EDGAR →

Eloxx Pharmaceuticals, Inc. (ELOX)

8-K Exec appointment confidence 95% filed 2026-10-21 Item 5.02

The Board appointed Geno J. Germano as a new director on October 19, 2026, increasing Board size from five to six members. Germano brings extensive pharmaceutical industry experience and public company board credentials.

View raw filing on EDGAR →

Eloxx Pharmaceuticals, Inc. (ELOX)

8-K Exec appointment confidence 75% filed 2026-10-21 Item 8.01

The Company appointed T.R. Srinivas, M.D. to the position of Senior Vice President and Chief Medical Officer, a named executive role material to the Company's clinical and regulatory strategy.

View raw filing on EDGAR →

reAlpha Tech Corp. (AIRE)

8-K Exec Compensation confidence 92% filed 2026-10-21 Item 8.01

The Board approved an updated non-executive director compensation policy effective March 9, 2026, establishing a total annual compensation structure of $100,000 per director ($75,000 in quarterly share awards plus $25,000 in cash). This is a compensatory arrangement disclosure under Item 8.01 that materially affects director compensation terms and would be relevant to investors assessing governance and capital allocation.

View raw filing on EDGAR →

Silicon Valley Acquisition Corp. (SVAQW)

8-K Debt Issuance confidence 94% filed 2026-10-21 Item 1.01

Silicon Valley Acquisition Corp. and EigenQ entered into a securities purchase agreement on October 19, 2026, providing for the issuance of subordinated unsecured promissory notes with an aggregate original principal amount of up to $5,000,000 and warrants, creating a material new direct financial obligation ahead of the Business Combination Closing.

View raw filing on EDGAR →

Silicon Valley Acquisition Corp. (SVAQW)

8-K Dilutive issuance confidence 92% filed 2026-10-21 Item 3.02

SVAQ issued unregistered equity securities in a private placement exempt under Section 4(a)(2) and Regulation D Rule 506(b), including unsecured notes convertible into equity and warrants with an aggregate purchase price of $2,172,000 plus additional notes and warrants to be issued in connection with the proposed Business Combination, materially dilutive to existing shareholders.

View raw filing on EDGAR →

SCHMID Group N.V. (SHMDW)

6-K Earnings release confidence 92% filed 2026-10-21 EX-99.1

SCHMID Group disclosed third quarter 2026 operational and financial results, including preliminary Q3 revenues of €24.0 million, cumulative nine-month revenues of €70.0 million, Q3 order intake of €67.8 million, and order backlog of €96.8 million as of September 30, 2026. The company updated full-year 2026 guidance, raising order intake guidance to more than €150 million while confirming revenue guidance of more than €100 million.

View raw filing on EDGAR →

SCHMID Group N.V. (SHMDW)

6-K Operational Other confidence 85% filed 2026-10-21 EX-99.2

SCHMID Group announced a significant equipment order valued at more than €25 million from a key customer to support HDI capacity expansion in Malaysia, demonstrating strong business momentum and reinforcing the company's competitive position in advanced electronics manufacturing.

View raw filing on EDGAR →

PSYENCE BIOMEDICAL LTD. (PBMWW)

6-K Financial Other confidence 75% filed 2026-10-21 EX-99.1

This press release announces completion of a US$2.6 million investment by Psyence BioMed in its related party PsyLabs upon achievement of specified milestones (regulatory readiness documentation and cGMP manufacturing agreement with Benuvia). The investment is material to shareholders as it represents a significant capital deployment, increases the Company's stake in PsyLabs from 41.13% to 43.37%, and advances the Company's ibogaine development program. While the investment itself is a financial transaction, it does not fit neatly into the specific financial event categories (debt_issuance, dividend_distribution, dilutive_issuance, material_impairment, or ma_activity), making financial_other the most appropriate classification.

View raw filing on EDGAR →

GOWell Energy Technology (GOW)

6-K Earnings release confidence 94% filed 2026-10-21 EX-99.1

GOWell Energy Technology announced first half 2026 financial results for its operating subsidiary GTL, reporting revenue of $33.8 million (43% YoY increase), operating profit of $9.1 million (135% increase), and net profit of $3.7 million (38% increase), along with full-year 2026 guidance of $60–$68 million revenue and $25–$29 million Adjusted EBITDA.

View raw filing on EDGAR →

INVE Technologies, Inc. (INVE)

8-K Earnings release confidence 75% filed 2026-10-21 Item 2.02

INVE Technologies disclosed preliminary unaudited financial results for Q3 2026, including revenue of $2.9–$3.1 million, net income of $0.4–$0.8 million, and EPS of $0.01–$0.02, via a press release dated October 21, 2026.

View raw filing on EDGAR →

Cellyan Biotechnology Co., Ltd (HKPD)

6-K Delisting risk confidence 92% filed 2026-10-21 EX-99.1

The press release announces a 1-for-20 reverse stock split effective October 26, 2026, explicitly stating the action is "primarily intended to enable the Company to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market." The disclosure acknowledges delisting risk by noting "there can be no assurance that the Company will regain compliance with such requirement within the applicable compliance period or maintain compliance with Nasdaq's continued listing requirement thereafter," which is a material disclosure of compliance failure and delisting threat.

View raw filing on EDGAR →

NewGenIvf Group Ltd (NIVFW)

6-K Governance Other confidence 85% filed 2026-10-21

The 6-K discloses a reverse stock split (1-for-8) approved by the Board on October 6, 2026, effective October 23, 2026, reducing outstanding Class A Ordinary Shares from approximately 9.8 million to 1.2 million. This is a governance and capital structure event that materially affects share count, trading mechanics, and shareholder equity positions, though it does not fit the specific named governance categories (exec appointment/departure, compensation, shareholder vote results). The disclosure is clearly governance-related and material to investors assessing the registrant's capitalization.

View raw filing on EDGAR →

Getty Images Holdings, Inc. (GETY)

8-K Bankruptcy Filing confidence 98% filed 2026-10-21 Item 1.03

Getty Images Holdings, Inc. and six subsidiaries filed voluntary petitions under Chapter 11 of the Bankruptcy Code on October 21, 2026, in the U.S. Bankruptcy Court for the District of Delaware, implementing a prepackaged reorganization plan supported by a restructuring support agreement with majority shareholders and funded debt holders. The Chapter 11 filing constituted an event of default accelerating approximately $1.4 billion in aggregate debt obligations across multiple instruments, and existing equity holders will receive no recovery under the plan.

View raw filing on EDGAR →

Zedge, Inc. (ZDGE)

8-K Operational Other confidence 72% filed 2026-10-21

This 8-K discloses an investor presentation (Item 7.01) detailing Zedge's strategic pivot toward DataSeeds, a B2B AI data business, supported by a ~$7.7M insider-led capital raise (with $6.5M from Howard Jonas). The filing emphasizes commercial validation (first six-figure order, repeat customers), new leadership (Morris Berger as CEO effective October 1, 2026), and a material shift in capital allocation (dividend continuation, buyback suspension). While the presentation touches on multiple domains—governance (CEO transition), financial (capital raise, cash position), and operational (business strategy)—the core disclosed event is a strategic business repositioning and capital infusion to accelerate a new growth initiative, which is fundamentally operational in nature.

View raw filing on EDGAR →

Elmet Group Co. (ELMT)

8-K M&A activity confidence 92% filed 2026-10-21 Item 1.01

Elmet Group entered into a binding subscription agreement with Blue Moon Metals Inc. on October 16, 2026, to purchase 3.5 million units (common shares and warrants) for CAD 35 million as a strategic investment in Blue Moon's Springer Tungsten Complex. The investment includes board representation rights, participation rights in future offerings, and anti-dilution protections.

View raw filing on EDGAR →

Elmet Group Co. (ELMT)

8-K Shareholder vote confidence 95% filed 2026-10-21 Item 5.07

Stockholders approved The Elmet Group Co. 2026 Employee Stock Purchase Plan at a Special Meeting held on October 19, 2026, with 23,300,321 votes in favor, 1,198,918 against, and 9,656 abstentions.

View raw filing on EDGAR →

Inmune Bio, Inc. (INMB)

8-K Operational Other confidence 75% filed 2026-10-21 Item 8.01

INmune Bio entered into a Master Services Agreement with Uniphar establishing a global commercialization framework for Ebstrocel™ in European and MENA markets via named-patient access, and accelerated regulatory timelines with a final pre-MAA package submitted to UK MHRA targeting potential UK approval in mid-2027 and U.S. BLA submission in Q2 2027.

View raw filing on EDGAR →

Silynxcom Ltd. (SYNX)

6-K Operational Other confidence 85% filed 2026-10-21 EX-99.1

This press release announces Silynxcom's strategic entry into the counter-drone defense (C-UAS) market through development of a new AI-powered wearable drone-detection platform. The disclosure emphasizes this represents "more than the development of a new product" and "marks our strategic entry into an entirely new defense market," positioning it as a potential "new business line and an additional growth engine." While not a discrete M&A transaction, this represents a material strategic business expansion into a projected $16.45 billion market by 2034, which would affect a reasonable investor's assessment of the company's growth prospects and market positioning.

View raw filing on EDGAR →

Luda Technology Group Ltd (LUD)

6-K Operational Other confidence 85% filed 2026-10-21 EX-99.1

Luda Technology announces entry into Mongolia-China coal trading business with binding supply agreements totaling 440,000 metric tons over one year, representing a material strategic expansion beyond its core steel flanges and fittings business into commodity trading. The press release discloses definitive customer and supplier agreements establishing quantity commitments and an operational framework, though pricing remains subject to market conditions. This is a significant operational and strategic business development that would affect a reasonable investor's assessment of the company's revenue diversification and business model, but does not fit the specific categories of M&A activity, debt issuance, or other named event types.

View raw filing on EDGAR →

TNL Mediagene (TNMWF)

6-K M&A activity confidence 95% filed 2026-10-21 EX-99.1

The press release announces entry into a Securities Purchase Agreement with Vector Advisory Partners for a $6.25 million strategic equity investment that is "expected to result in a change of control of the Company," with Vector holding approximately 80% of fully diluted ordinary shares on an as-converted basis following required approvals. This constitutes a material change-of-control transaction under Item 1.01 / 2.01 of the 8-K taxonomy, directly analogous to M&A activity requiring disclosure.

View raw filing on EDGAR →

Ping An Biomedical Co., Ltd. (PASW)

6-K Governance Other confidence 85% filed 2026-10-21 EX-99.1

This press release announces a 1-for-40 reverse stock split of Ping An Biomedical's Class A and Class B ordinary shares, effective October 23, 2026. The reverse split is a governance and capital structure event approved by the board on August 6, 2026, and previously authorized by shareholders at an extraordinary general meeting on March 18, 2026. While reverse splits are sometimes routine, this one materially affects share count (from ~112.9M to ~2.8M Class A shares) and par value, and would affect a reasonable investor's assessment of the company's capital structure and share valuation metrics.

View raw filing on EDGAR →

Valor Energy Inc (AIHS)

8-K Dilutive issuance confidence 85% filed 2026-10-21 Item 3.02

Item 3.02 discloses the closing of a private placement of warrants to purchase 4,510,000 shares of restricted common stock, issued pursuant to Section 4(a)(2) and Rule 506(d) of Regulation D—an unregistered sale of equity securities. This is a classic dilutive issuance that would materially affect a reasonable investor's assessment of ownership dilution and capital structure.

View raw filing on EDGAR →